News Details

Veeco Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 16, 2022

Fourth Quarter 2021 Highlights:

  • Revenues of $153.0 million, compared with $138.9 million in the same period last year
  • GAAP net income of $8.2 million, or $0.15 per diluted share, compared with a net loss of $0.1 million, or $(0.00) per diluted share in the same period last year
  • Non-GAAP net income of $22.6 million, or $0.43 per diluted share, compared with $15.0 million, or $0.30 per diluted share in the same period last year

Full Year 2021 Highlights:

  • Revenues of $583.3 million, compared with $454.2 million last year
  • GAAP net income of $26.0 million, or $0.49 per diluted share, compared with a net loss of $8.4 million, or $(0.17) per diluted share last year
  • Non-GAAP net income of $73.6 million, or $1.43 per diluted share, compared with $42.3 million, or $0.86 per diluted share last year

PLAINVIEW, N.Y., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its fourth quarter and fiscal year ended December 31, 2021. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

                         
U.S. Dollars in millions, except per share data                        
                         
    4th Quarter   Full Year
GAAP Results   Q4 '21   Q4 '20   2021   2020  
Revenue   $ 153.0   $ 138.9     $ 583.3   $ 454.2  
Net income (loss)   $ 8.2   $ (0.1 )   $ 26.0   $ (8.4 )
Diluted earnings (loss) per share   $ 0.15   $ (0.00 )   $ 0.49   $ (0.17 )

 

                             
    4th Quarter   Full Year
Non-GAAP Results   Q4 '21   Q4 '20   2021   2020
Operating income   $ 24.9   $ 17.6     $ 86.6   $ 52.5  
Net income   $ 22.6   $ 15.0     $ 73.6   $ 42.3  
Diluted earnings per share   $ 0.43   $ 0.30     $ 1.43   $ 0.86  
                             

“I am proud of our many accomplishments in 2021,” commented Bill Miller, Veeco’s Chief Executive Officer. “We successfully advanced our product innovation and penetrated new customers, enhanced our service capabilities, increased our manufacturing capacity, improved our capital structure, solidified our governance and commitment to corporate responsibility, and strengthened the Veeco United culture. In September, we announced long-term financial targets and made immediate progress toward those targets with significant revenue and EPS growth in 2021.”

“We had solid results in the fourth quarter with revenue and EPS exceeding the midpoint of our guidance,” continued Mr. Miller. “Demand in our semiconductor and compound semiconductor markets is exceptionally strong and we exited 2021 with order momentum, increased backlog and exciting opportunities that will support our growth strategy.”

Guidance and Outlook

The following guidance is provided for Veeco’s first quarter 2022:

  • Revenue is expected in the range of $145 million to $165 million
  • GAAP diluted earnings per share are expected in the range of $0.15 to $0.32
  • Non-GAAP diluted earnings per share are expected in the range of $0.28 to $0.44

The above issued guidance takes into account the impact of the adoption of ASU 2020-06, effective January 1, 2022, which includes the reduction of non-cash interest expense for GAAP purposes, and the calculation of diluted earnings per share using the if-converted method for both GAAP and non-GAAP purposes. Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, February 16, 2022 starting at 5:00pm ET. To join the call, dial 1-888-220-8451 (toll free) or 1-646-828-8193 and use passcode 9212833. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, the impact of the COVID-19 pandemic, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

       
Veeco Contacts:       
       
Investors:  Anthony Bencivenga (516) 252-1438  abencivenga@veeco.com  
Media: Kevin Long (516) 714-3978     klong@veeco.com  
       

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)

                         
    Three months ended December 31,   Year ended December 31,
       2021        2020        2021        2020  
Net sales   $ 152,972     $ 138,946     $ 583,277     $ 454,163  
Cost of sales     88,949       82,101       341,003       259,863  
Gross profit     64,023       56,845       242,274       194,300  
Operating expenses, net:                        
Research and development     22,283       21,417       88,680       78,994  
Selling, general, and administrative     21,211       20,710       84,536       76,251  
Amortization of intangible assets     2,974       3,831       12,280       15,333  
Restructuring                       1,097  
Asset impairment                       281  
Other operating expense (income), net     (71 )     281       68       (221 )
Total operating expenses, net     46,397       46,239       185,564       171,735  
Operating income (loss)     17,626       10,606       56,710       22,565  
Interest expense, net     (5,799 )     (6,516 )     (26,020 )     (23,188 )
Other income (expense), net     (5,010 )     (4,794 )     (5,010 )     (7,841 )
Income (loss) before income taxes     6,817       (704 )     25,680       (8,464 )
Income tax expense (benefit)     (1,387 )     (602 )     (358 )     (73 )
Net income (loss)   $ 8,204     $ (102 )   $ 26,038     $ (8,391 )
                         
Income (loss) per common share:                        
Basic   $ 0.17     $ (0.00 )   $ 0.53     $ (0.17 )
Diluted   $ 0.15     $ (0.00 )   $ 0.49     $ (0.17 )
                         
Weighted average number of shares:                        
Basic     49,187       48,340       49,073       48,362  
Diluted     54,931       48,340       53,643       48,362  
                                 

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)

             
    December 31,   December 31,
       2021      2020
    (unaudited)      
Assets            
Current assets:            
Cash and cash equivalents   $ 119,747   $ 129,625
Restricted cash     725     658
Short-term investments     104,181     189,771
Accounts receivable, net     109,609     79,991
Contract assets     18,293     21,246
Inventories     170,858     145,906
Deferred cost of sales     346     433
Prepaid expenses and other current assets     25,628     19,301
Total current assets     549,387     586,931
Property, plant and equipment, net     99,743     65,271
Operating lease right-of-use assets     28,813     10,275
Intangible assets, net     33,905     46,185
Goodwill     181,943     181,943
Deferred income taxes     1,639     1,440
Other assets     3,546     6,019
Total assets   $ 898,976   $ 898,064
             
Liabilities and stockholders’ equity            
Current liabilities:            
Accounts payable   $ 44,456   $ 33,656
Accrued expenses and other current liabilities     79,752     44,876
Customer deposits and deferred revenue     63,136     67,235
Income taxes payable     1,860     914
Total current liabilities     189,204     146,681
Deferred income taxes     4,792     5,240
Long-term debt     229,438     321,115
Long-term operating lease liabilities     32,834     6,305
Other liabilities     5,080     10,349
Total liabilities     461,348     489,690
             
Total stockholders’ equity     437,628     408,374
Total liabilities and stockholders’ equity   $ 898,976   $ 898,064
             

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

                           
          Non-GAAP Adjustments        
          Share-Based                
Three months ended December 31, 2021      GAAP      Compensation      Amortization      Other      Non-GAAP  
Net sales   $ 152,972               $ 152,972  
Gross profit     64,023   608         235       64,866  
Gross margin     41.9 %               42.4 %
Operating expenses     46,397   (2,906 )   (2,974 )   (537 )     39,980  
Operating income (loss)     17,626   3,514     2,974     772   ^   24,886  
Net income (loss)     8,204   3,514     2,974     7,950   ^   22,642  
                           
Income (loss) per common share:                          
Basic   $ 0.17               $ 0.46  
Diluted     0.15                 0.43  
Weighted average number of shares:                          
Basic     49,187                 49,187  
Diluted (1)     54,931                 52,761  

 

____________
^ - See table below for additional details.
   
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the Company is in a net income position. The average stock price for the three months ended December 31, 2021 was $25.53, and therefore 1.9 million shares were included in the non-GAAP diluted share count, and 4.0 million shares were included in the GAAP diluted share count related to the 2027 Notes.
   

Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

     
Three months ended December 31, 2021       
Transition expenses related to San Jose expansion project $ 698  
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting   74  
Subtotal   772  
Non-cash interest expense   3,057  
Other (income) expense, net   5,010  
Non-GAAP tax adjustment *   (889 )
Total Other $ 7,950  

 

____________
* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.
   

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

                           
          Non-GAAP Adjustments        
          Share-based              
Three months ended December 31, 2020        GAAP      Compensation      Amortization      Other      Non-GAAP  
Net sales   $ 138,946                 $ 138,946  
Gross profit     56,845     486         20       57,351  
Gross margin     40.9   %               41.3 %
Operating expenses     46,239     (2,656 )   (3,831 )   (41 )     39,711  
Operating income (loss)     10,606     3,142     3,831     61   ^   17,640  
Net income (loss)     (102 )   3,142     3,831     8,085   ^   14,956  
                           
Income (loss) per common share:                          
Basic   $ (0.00 )               $ 0.31  
Diluted     (0.00 )                 0.30  
Weighted average number of shares:                          
Basic     48,340                   48,340  
Diluted     48,340                   49,663  

 

____________
^ - See table below for additional details.
   

Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

     
Three months ended December 31, 2020    
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting $ 61  
Subtotal   61  
Non-cash interest expense   3,511  
Other (income) expense, net   4,794  
Non-GAAP tax adjustment *   (281 )
Total Other $ 8,085  

 

____________
* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.
   

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)

             
       Three months ended      Three months ended
    December 31, 2021   December 31, 2020
GAAP Net income (loss)   $ 8,204     $ (102 )
Share-based compensation     3,514       3,142  
Amortization     2,974       3,831  
Transition expenses related to San Jose expansion project     698        
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting     74       61  
Interest (income) expense, net     5,799       6,516  
Other (income) expense, net     5,010       4,794  
Income tax expense (benefit)     (1,387 )     (602 )
Non-GAAP Operating income (loss)   $ 24,886     $ 17,640  
                 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

                           
          Non-GAAP Adjustments        
          Share-based              
For the year ended December 31, 2021        GAAP      Compensation      Amortization      Other      Non-GAAP  
Net sales   $ 583,277               $ 583,277  
Gross profit     242,274   2,373         448       245,095  
Gross margin     41.5 %               42.0 %
Operating expenses     185,564   (12,876 )   (12,280 )   (1,918 )     158,490  
Operating income (loss)     56,710   15,249     12,280     2,366   ^   86,605  
Net income (loss)     26,038   15,249     12,280     20,082   ^   73,649  
                           
Income (loss) per common share:                          
Basic   $ 0.53               $ 1.50  
Diluted     0.49                 1.43  
Weighted average number of shares:                          
Basic     49,073                 49,073  
Diluted     53,643                 51,472  

 

____________
^ - See table below for additional details.
   
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the Company is in a net income position. The average stock price for the fiscal year ended December 31, 2021 was $22.89, and therefore 1.3 million shares were included in the non-GAAP diluted share count, and 3.5 million shares were included in the GAAP diluted share count related to the 2027 Notes.
   

Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

     
For the year ended December 31, 2021       
Transition expenses related to San Jose expansion project   2,021  
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting   345  
Subtotal   2,366  
Non-cash interest expense   13,819  
Other (income) expense, net   5,010  
Non-GAAP tax adjustment *   (1,113 )
Total Other $ 20,082  
       

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

                             
            Non-GAAP Adjustments        
            Share-based              
For the year ended December 31, 2020          GAAP      Compensation      Amortization      Other      Non-GAAP  
Net sales   $   454,163                 $ 454,163  
Gross profit       194,300     1,870         348       196,518  
Gross margin       42.8   %               43.3 %
Operating expenses       171,735     (10,833 )   (15,333 )   (1,530 )     144,039  
Operating income (loss)       22,565     12,703     15,333     1,878   ^   52,479  
Net income (loss)       (8,391 )   12,703     15,333     22,684   ^   42,329  
                             
Income (loss) per common share:                            
Basic   $   (0.17 )               $ 0.88  
Diluted       (0.17 )                 0.86  
Weighted average number of shares:                            
Basic       48,362                   48,362  
Diluted       48,362                   49,309  

 

____________
^ - See table below for additional details.
   

   

Veeco Instruments Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

     
For the year ended December 31, 2020    
Restructuring $ 1,097  
Asset impairment   281  
Release of inventory fair value step-up associated with the Ultratech purchase accounting   273  
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting   227  
Subtotal   1,878  
Non-cash interest expense   13,792  
Other (income) expense, net   7,841  
Non-GAAP tax adjustment *   (827 )
Total Other $ 22,684  
       

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)

             
       Year ended      Year ended
    December 31, 2021   December 31, 2020
GAAP Net income (loss)   $ 26,038     $ (8,391 )
Share-based compensation     15,249       12,703  
Amortization     12,280       15,333  
Transition expenses related to San Jose expansion project     2,021        
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting     345       227  
Restructuring           1,097  
Asset impairment           281  
Release of inventory fair value step-up associated with the Ultratech purchase accounting           273  
Interest (income) expense, net     26,020       23,188  
Other (income) expense, net     5,010       7,841  
Income tax expense (benefit)     (358 )     (73 )
Non-GAAP Operating income (loss)   $ 86,605     $ 52,479  
                 

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

 

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in millions, except per share amounts)
(unaudited)

                                             
                    Non-GAAP Adjustments                
Guidance for the three months ending                   Share-based                        
March 31, 2022   GAAP   Compensation   Amortization       Other        Non-GAAP
Net sales   $ 145     -   $ 165                 $ 145     -   $ 165  
Gross profit     58     -     71     1         1       60     -     73  
Gross margin     41 %   -     43 %                 42 %   -     44 %
Operating expenses     48     -     50     (3 )   (3 )   (1 )     42     -     44  
Operating income (loss)     10     -     21     4     3     1       18     -     29  
Net income (loss)   $ 7     -   $ 18     4     3     1     $ 15     -   $ 26  
                                             
Income (loss) per diluted common share   $ 0.15     -   $ 0.32                 $ 0.28     -   $ 0.44  
                                                     

Veeco Instruments Inc. and Subsidiaries
Income (Loss) per Diluted Common Share
(in millions, except per share amounts)
(unaudited)

                                   
Guidance for the three months ending March 31, 2022   GAAP   Non-GAAP  
Net income   $ 7   -   $ 18   $ 15   -   $ 26  
Add: Interest on Convertible Senior Notes     2         3     2         2  
Net income available to common shareholders   $ 9   -   $ 21   $ 17   -   $ 28  
                                   
Basic weighted average common shares     49         49     49         49  
Add: Dilutive effect of share-based awards     2         2     2         2  
Add: Dilutive effect of 2023 Convertible Senior Notes                          
Add: Dilutive effect of 2025 Convertible Senior Notes             6     6         6  
Add: Dilutive effect of 2027 Convertible Senior Notes (1)     9         9     7         7  
Diluted weighted average common shares     60         66     64         64  
                                   
Income (loss) per diluted common share   $ 0.15   -   $ 0.32   $ 0.28   -   $ 0.44  

 

____________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count
   

Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)
(in millions)
(unaudited)

                 
Guidance for the three months ending March 31, 2022                         
GAAP Net income (loss)   $ 7   -   $ 18
Share-based compensation     4   -     4
Amortization     3   -     3
Interest expense, net     3   -     3
Other     1   -     1
Non-GAAP Operating income (loss)   $ 18   -   $ 29

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.


Primary Logo

Source: Veeco Instruments Inc.